Be a champion for change
A n estimated 50,000 people who die from cancer every year could still be alive if the quality of diagnosis and care in European countries with the poorest survival rates were as good as the median [more]
diagnosis
Math models for medical decision-making: a double-edged sword
In the golden age of computing, both the present and future of medical decision-making seem to depend on new mathematical models and systems built around artificial intelligence (AI). But how will doctors and patients feel [more]
Rare cancers account for one fifth of new diagnoses in the US
According to an analysis just published on American Cancer Society’s CA: A Cancer Journal for Clinicians, rare cancers account for almost a fifth of all new diagnoses, and up to over two thirds of all new diagnoses [more]
Primary therapy of early hepatobiliary and pancreatic cancers: a review of the latest evidence
The state of the art on the diagnosis and management of cancer of the pancreas and hepatobiliary system was the focus of the 3rd St Gallen Gastrointestinal Cancer Conference, held earlier this year under the [more]
Madrid (Spain) 19/05/2016 – ESO, CNIO and NRCO Conference on Familial Cancer
ESO, CNIO and NRCO Conference on Familial Cancer 19/05/2016 – 20/05/2016, Madrid, Spain Chairs: R. Eeles, UK – W.D. Foulkes, CA – M. Robledo, ES – H. Vasen, NL The ESO, CNIO and NRCO Conference [more]
Multiparametric MRI in prostate cancer
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other [more]